Merz Pharmaceuticals today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Xeomin® (incobotulinumtoxinA), a botulinum toxin type A for the treatment of adults ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback